Biocryst Pharmaceuticals buy Evercore ISI
Start price
13.01.25
/
50%
€7.73
Target price
13.01.26
€11.76
Performance (%)
-25.83%
End price
14.01.26
€5.73
Summary
This prediction ended on 14.01.26 with a price of €5.73. The price of Biocryst Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.83%. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -0.760% | -0.760% | 20.518% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by Evercore_ISI for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Evercore ISI from $10.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Evercore_ISI for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€9.11
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24
